검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | intralipid (intralipid) Johnson & Johnson Pharmaceutical R…·Pregnancy Complicated by Low Impla… 54 trials |
|---|---|
Overview Program | intralipid |
Overview Company | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Overview Modality | CGT |
Overview Target | Pregnancy Complicated by Low Implantatio |
Overview Indication | Pregnancy Complicated by Low Implantation |
Overview Phase | APPROVED |
Overview Status | DISCONTINUED |
MoA Mechanism | targets (TLR9, ALPL, PTGS2) and metabolic pathway |
MoA Biomarker | biomarker |
PK/PD Species | Rat |
PK/PD Animal (cat.) | Rat |
PK/PD Experiment | pharmacokinetic |
Toxicology Species | Rat |
Toxicology Animal (cat.) | Rat |
Toxicology Major finding | Evaluation of Intravenous Lipid Emulsion as an Adjunctive Antidote in Experimental Fentanyl Toxicity: Comparison with Naloxone in a Rat Model.. Fentanyl is an extremely potent and highly lipophilic synthetic opioid, whose toxicity is marked by significant respiratory depression and central nervous system impairment. Naloxone is the primary antidote for opioid overdose; however, there is an increas… |
Clinical Data Tier / Score | A · 21 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | intralipid (intralipid) Johnson & Johnson Pharmaceutical R…·Pregnancy Complicated by Low Impla… 54 trials |
|---|---|
Overview Program | intralipid |
Overview Company | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Overview Modality | CGT |
Overview Target | Pregnancy Complicated by Low Implantatio |
Overview Indication | Pregnancy Complicated by Low Implantation |
Overview Phase | APPROVED |
Overview Status | DISCONTINUED |
MoA Mechanism | targets (TLR9, ALPL, PTGS2) and metabolic pathway |
MoA Biomarker | biomarker |
PK/PD Species | Rat |
PK/PD Animal (cat.) | Rat |
PK/PD Experiment | pharmacokinetic |
Toxicology Species | Rat |
Toxicology Animal (cat.) | Rat |
Toxicology Major finding | Evaluation of Intravenous Lipid Emulsion as an Adjunctive Antidote in Experimental Fentanyl Toxicity: Comparison with Naloxone in a Rat Model.. Fentanyl is an extremely potent and highly lipophilic synthetic opioid, whose toxicity is marked by significant respiratory depression and central nervous system impairment. Naloxone is the primary antidote for opioid overdose; however, there is an increas… |
Clinical Data Tier / Score | A · 21 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
추천 비교
추천 비교